Andreas Puschmann

VPS35 Mutations in Parkinson Disease

Carles Vilariño‐Güell, Christian Wider, Owen A. Ross et al. · The American Journal of Human Genetics · 2011 · 893 citations · Full text

Life Sciences, Genetics, Neuroscience +13

Clinical Correlations With Lewy Body Pathology in<i>LRRK2</i>-Related Parkinson Disease

Lorraine V. Kalia, Anthony E. Lang, Lili‐Naz Hazrati et al. · JAMA Neurology · 2014 · 407 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study

Owen A. Ross, Alexandra I. Soto‐Ortolaza, Michael G. Heckman et al. · The Lancet Neurology · 2011 · 344 citations · Full text

Life Sciences, Genetics, Molecular Genetics +12

Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms

Bianca Tesi, Josef Davidsson, Elisa Rahikkala et al. · Blood · 2017 · 202 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

¹⁸ F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in <i>MAPT</i> mutation carriers

Ruben Smith, Andreas Puschmann, Michael Schöll et al. · Brain · 2016 · 172 citations · Full text

Life Sciences, Neurology, Neuroscience +17